nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymetazoline—HTR2A—Gilles de la Tourette syndrome	0.752	1	CbGaD
Oxymetazoline—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00533	0.089	CbGeAlD
Oxymetazoline—HTR1E—nervous system—Gilles de la Tourette syndrome	0.00297	0.0495	CbGeAlD
Oxymetazoline—HTR1E—central nervous system—Gilles de la Tourette syndrome	0.00285	0.0476	CbGeAlD
Oxymetazoline—NISCH—midbrain—Gilles de la Tourette syndrome	0.00265	0.0442	CbGeAlD
Oxymetazoline—HTR1E—brain—Gilles de la Tourette syndrome	0.00227	0.0378	CbGeAlD
Oxymetazoline—ADRA1B—nervous system—Gilles de la Tourette syndrome	0.00186	0.031	CbGeAlD
Oxymetazoline—ADRA1D—nervous system—Gilles de la Tourette syndrome	0.00182	0.0303	CbGeAlD
Oxymetazoline—ADRA1B—central nervous system—Gilles de la Tourette syndrome	0.00179	0.0298	CbGeAlD
Oxymetazoline—ADRA1D—central nervous system—Gilles de la Tourette syndrome	0.00175	0.0292	CbGeAlD
Oxymetazoline—HTR1B—midbrain—Gilles de la Tourette syndrome	0.00171	0.0285	CbGeAlD
Oxymetazoline—NISCH—brain—Gilles de la Tourette syndrome	0.00166	0.0278	CbGeAlD
Oxymetazoline—HTR1D—midbrain—Gilles de la Tourette syndrome	0.00165	0.0276	CbGeAlD
Oxymetazoline—HTR2C—midbrain—Gilles de la Tourette syndrome	0.00164	0.0273	CbGeAlD
Oxymetazoline—ADRA1B—brain—Gilles de la Tourette syndrome	0.00142	0.0237	CbGeAlD
Oxymetazoline—HTR1B—nervous system—Gilles de la Tourette syndrome	0.0014	0.0234	CbGeAlD
Oxymetazoline—ADRA1D—brain—Gilles de la Tourette syndrome	0.00139	0.0232	CbGeAlD
Oxymetazoline—HTR1D—nervous system—Gilles de la Tourette syndrome	0.00136	0.0227	CbGeAlD
Oxymetazoline—HTR1B—central nervous system—Gilles de la Tourette syndrome	0.00135	0.0225	CbGeAlD
Oxymetazoline—HTR2C—nervous system—Gilles de la Tourette syndrome	0.00134	0.0224	CbGeAlD
Oxymetazoline—HTR1D—central nervous system—Gilles de la Tourette syndrome	0.00131	0.0218	CbGeAlD
Oxymetazoline—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.00129	0.0216	CbGeAlD
Oxymetazoline—HTR2B—nervous system—Gilles de la Tourette syndrome	0.00126	0.0211	CbGeAlD
Oxymetazoline—HTR2B—central nervous system—Gilles de la Tourette syndrome	0.00122	0.0203	CbGeAlD
Oxymetazoline—ADRA2C—midbrain—Gilles de la Tourette syndrome	0.00121	0.0202	CbGeAlD
Oxymetazoline—HTR1B—brain—Gilles de la Tourette syndrome	0.00107	0.0179	CbGeAlD
Oxymetazoline—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.00104	0.0174	CbGeAlD
Oxymetazoline—HTR1D—brain—Gilles de la Tourette syndrome	0.00104	0.0173	CbGeAlD
Oxymetazoline—HTR2C—brain—Gilles de la Tourette syndrome	0.00103	0.0171	CbGeAlD
Oxymetazoline—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.001	0.0168	CbGeAlD
Oxymetazoline—ADRA2C—nervous system—Gilles de la Tourette syndrome	0.000994	0.0166	CbGeAlD
Oxymetazoline—HTR2B—brain—Gilles de la Tourette syndrome	0.000965	0.0161	CbGeAlD
Oxymetazoline—ADRA2A—midbrain—Gilles de la Tourette syndrome	0.000965	0.0161	CbGeAlD
Oxymetazoline—ADRA2C—central nervous system—Gilles de la Tourette syndrome	0.000957	0.016	CbGeAlD
Oxymetazoline—HTR2A—midbrain—Gilles de la Tourette syndrome	0.00082	0.0137	CbGeAlD
Oxymetazoline—ADRA1A—brain—Gilles de la Tourette syndrome	0.000797	0.0133	CbGeAlD
Oxymetazoline—ADRA2A—nervous system—Gilles de la Tourette syndrome	0.000793	0.0132	CbGeAlD
Oxymetazoline—ADRA2A—central nervous system—Gilles de la Tourette syndrome	0.000764	0.0127	CbGeAlD
Oxymetazoline—ADRA2C—brain—Gilles de la Tourette syndrome	0.00076	0.0127	CbGeAlD
Oxymetazoline—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000674	0.0113	CbGeAlD
Oxymetazoline—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000649	0.0108	CbGeAlD
Oxymetazoline—ADRA2A—brain—Gilles de la Tourette syndrome	0.000606	0.0101	CbGeAlD
Oxymetazoline—HTR2A—brain—Gilles de la Tourette syndrome	0.000516	0.0086	CbGeAlD
Oxymetazoline—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000195	0.00104	CbGpPWpGaD
Oxymetazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000195	0.00104	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000192	0.00102	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000192	0.00102	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00019	0.00101	CbGpPWpGaD
Oxymetazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000189	0.00101	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000189	0.00101	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000188	0.001	CbGpPWpGaD
Oxymetazoline—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000187	0.000996	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000187	0.000992	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000187	0.000992	CbGpPWpGaD
Oxymetazoline—ADRA2A—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000186	0.00099	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000186	0.000988	CbGpPWpGaD
Oxymetazoline—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000185	0.000983	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000184	0.00098	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000183	0.000972	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000183	0.000971	CbGpPWpGaD
Oxymetazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000182	0.000969	CbGpPWpGaD
Oxymetazoline—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000182	0.000967	CbGpPWpGaD
Oxymetazoline—ADRA2A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000181	0.000961	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00018	0.000959	CbGpPWpGaD
Oxymetazoline—HTR1E—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00018	0.000955	CbGpPWpGaD
Oxymetazoline—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000179	0.000953	CbGpPWpGaD
Oxymetazoline—HTR2C—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000179	0.000952	CbGpPWpGaD
Oxymetazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000177	0.00094	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000177	0.00094	CbGpPWpGaD
Oxymetazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000176	0.000938	CbGpPWpGaD
Oxymetazoline—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000174	0.000925	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000174	0.000924	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000173	0.000918	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000172	0.000913	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000172	0.000913	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000172	0.000913	CbGpPWpGaD
Oxymetazoline—ADRA1B—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000172	0.000912	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00017	0.000905	CbGpPWpGaD
Oxymetazoline—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000169	0.000901	CbGpPWpGaD
Oxymetazoline—ADRA2A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000168	0.000895	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000168	0.000894	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000168	0.000892	CbGpPWpGaD
Oxymetazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000165	0.000876	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000165	0.000875	CbGpPWpGaD
Oxymetazoline—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000163	0.000865	CbGpPWpGaD
Oxymetazoline—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000162	0.000862	CbGpPWpGaD
Oxymetazoline—HTR1E—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00016	0.000852	CbGpPWpGaD
Oxymetazoline—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00016	0.000852	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00016	0.00085	CbGpPWpGaD
Oxymetazoline—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00016	0.00085	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00016	0.000849	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00016	0.000849	CbGpPWpGaD
Oxymetazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000159	0.000847	CbGpPWpGaD
Oxymetazoline—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000158	0.00084	CbGpPWpGaD
Oxymetazoline—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000157	0.000832	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000156	0.000831	CbGpPWpGaD
Oxymetazoline—HTR1E—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000156	0.000827	CbGpPWpGaD
Oxymetazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000155	0.000822	CbGpPWpGaD
Oxymetazoline—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000153	0.000815	CbGpPWpGaD
Oxymetazoline—ADRA1A—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000152	0.00081	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000149	0.000791	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000149	0.00079	CbGpPWpGaD
Oxymetazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000148	0.000787	CbGpPWpGaD
Oxymetazoline—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000147	0.000782	CbGpPWpGaD
Oxymetazoline—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000147	0.000782	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000146	0.000774	CbGpPWpGaD
Oxymetazoline—HTR1E—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000145	0.00077	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000144	0.000767	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000144	0.000767	CbGpPWpGaD
Oxymetazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000144	0.000766	CbGpPWpGaD
Oxymetazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000144	0.000764	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000143	0.000758	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000141	0.000751	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000139	0.000738	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000138	0.000736	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000138	0.000736	CbGpPWpGaD
Oxymetazoline—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000137	0.000728	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000137	0.000726	CbGpPWpGaD
Oxymetazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000136	0.000724	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000135	0.000716	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000135	0.000716	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000134	0.000714	CbGpPWpGaD
Oxymetazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000134	0.000712	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—HDC—Gilles de la Tourette syndrome	0.000133	0.000707	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000133	0.000705	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000133	0.000705	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000132	0.0007	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000129	0.000686	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000125	0.000667	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000124	0.000659	CbGpPWpGaD
Oxymetazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000124	0.000657	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000124	0.000657	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000122	0.000647	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000121	0.000645	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00012	0.000639	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000119	0.000634	CbGpPWpGaD
Oxymetazoline—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000119	0.000631	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000118	0.000626	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000118	0.000626	CbGpPWpGaD
Oxymetazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000115	0.000614	CbGpPWpGaD
Oxymetazoline—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000114	0.000604	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000113	0.000599	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000112	0.000596	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000112	0.000595	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00011	0.000583	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000109	0.000582	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000109	0.000582	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000109	0.000578	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—HDC—Gilles de la Tourette syndrome	0.000108	0.000574	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000106	0.000566	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000105	0.000561	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000104	0.000554	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000103	0.000549	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000102	0.000542	CbGpPWpGaD
Oxymetazoline—HTR1E—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000102	0.00054	CbGpPWpGaD
Oxymetazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000101	0.000536	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	9.99e-05	0.000531	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	9.87e-05	0.000524	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	9.83e-05	0.000522	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	9.7e-05	0.000516	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	9.66e-05	0.000514	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	9.62e-05	0.000511	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	9.58e-05	0.000509	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	9.41e-05	0.0005	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	9.38e-05	0.000499	CbGpPWpGaD
Oxymetazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	9.37e-05	0.000498	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	9.3e-05	0.000494	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	9.22e-05	0.00049	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	9.07e-05	0.000482	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	9.04e-05	0.00048	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	9.04e-05	0.00048	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	9.03e-05	0.00048	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	8.92e-05	0.000474	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	8.81e-05	0.000468	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	8.79e-05	0.000467	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	8.74e-05	0.000464	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	8.65e-05	0.00046	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	8.6e-05	0.000457	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	8.44e-05	0.000449	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	8.41e-05	0.000447	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	8.39e-05	0.000446	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	8.35e-05	0.000444	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	8.21e-05	0.000436	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	8.2e-05	0.000436	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	8.15e-05	0.000433	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	8.06e-05	0.000429	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	7.84e-05	0.000417	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	7.83e-05	0.000416	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	7.77e-05	0.000413	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	7.72e-05	0.00041	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.68e-05	0.000408	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	7.64e-05	0.000406	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	7.62e-05	0.000405	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	7.61e-05	0.000405	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	7.59e-05	0.000404	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	7.49e-05	0.000398	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	7.4e-05	0.000393	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	7.32e-05	0.000389	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	7.29e-05	0.000388	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.14e-05	0.000379	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	7.12e-05	0.000379	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	7.11e-05	0.000378	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	7.09e-05	0.000377	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	7.01e-05	0.000373	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	7e-05	0.000372	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6.98e-05	0.000371	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.91e-05	0.000367	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.89e-05	0.000366	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	6.88e-05	0.000366	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.86e-05	0.000364	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.8e-05	0.000362	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.8e-05	0.000361	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	6.74e-05	0.000358	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.65e-05	0.000354	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.62e-05	0.000352	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.44e-05	0.000342	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.37e-05	0.000339	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.36e-05	0.000338	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.34e-05	0.000337	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6.33e-05	0.000337	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	6.33e-05	0.000336	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	6.25e-05	0.000332	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.23e-05	0.000331	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6.2e-05	0.00033	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.18e-05	0.000329	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.17e-05	0.000328	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	6.12e-05	0.000325	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.04e-05	0.000321	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.89e-05	0.000313	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	5.83e-05	0.00031	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.78e-05	0.000307	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.76e-05	0.000306	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.75e-05	0.000306	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	5.75e-05	0.000306	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	5.71e-05	0.000303	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	5.66e-05	0.000301	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.63e-05	0.000299	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.61e-05	0.000298	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	5.54e-05	0.000295	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	5.45e-05	0.000289	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	5.36e-05	0.000285	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	5.35e-05	0.000284	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.32e-05	0.000283	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	5.27e-05	0.00028	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.23e-05	0.000278	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	5.2e-05	0.000277	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	5.16e-05	0.000274	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.11e-05	0.000271	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.99e-05	0.000265	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.97e-05	0.000264	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.89e-05	0.00026	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.85e-05	0.000258	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.84e-05	0.000257	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.83e-05	0.000257	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.64e-05	0.000247	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.51e-05	0.00024	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.51e-05	0.00024	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.5e-05	0.000239	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.44e-05	0.000236	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.37e-05	0.000232	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.34e-05	0.000231	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.32e-05	0.00023	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.21e-05	0.000224	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.2e-05	0.000223	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.14e-05	0.00022	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.08e-05	0.000217	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.07e-05	0.000217	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.03e-05	0.000214	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.02e-05	0.000214	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.94e-05	0.00021	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.91e-05	0.000208	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.8e-05	0.000202	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.76e-05	0.0002	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.74e-05	0.000199	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.69e-05	0.000196	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.68e-05	0.000195	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.66e-05	0.000195	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.65e-05	0.000194	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.61e-05	0.000192	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.57e-05	0.00019	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.42e-05	0.000182	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.4e-05	0.000181	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.4e-05	0.000181	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.33e-05	0.000177	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.32e-05	0.000176	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.16e-05	0.000168	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.09e-05	0.000164	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.85e-05	0.000152	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.74e-05	0.000146	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.66e-05	0.000142	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.62e-05	0.000139	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.33e-05	0.000124	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.16e-05	0.000115	CbGpPWpGaD
